Premier Alternatives

Grove Biopharma

Chicago, IL · Founded 2020 · Privately Held (backing)

Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. Grove Biopharma is based in Chicago, IL and was founded in 2020. Its last reported valuation was $64 million in Apr 2025. It has raised $44 million.

Last reported valuation
$64.0M
Oct 2026
Priced at
—
Total raised
$44.0M
Last round
—

Grove Biopharma key facts

as of Oct 2026
  • Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases.
  • Grove Biopharma is valued at approximately $64.0M as of Oct 2026 (last reported valuation).
  • It has raised $44.0M; the latest was Later Stage VC ($36.0M) in Apr 2025.
  • Notable investors include DCVC Bio, Skydeck Capital, Mansueto Office, Deepwork Capital, Eli Lilly — 13 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$64.0M

Grove Biopharma's last reported valuation, Apr 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Grove Biopharma with a free account
  • ·The complete investor list: 13 names
  • ·Watch Grove Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Grove Biopharma funding rounds

No rounds on record

No funding rounds for Grove Biopharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Grove Biopharma valuation

Grove Biopharma's last reported valuation was $64 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.

Grove Biopharma investors

13 investors are on record for Grove Biopharma, including DCVC Bio, Skydeck Capital, Mansueto Office and Deepwork Capital.

About Grove Biopharma

Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. The company uses artificial intelligence and precision polymer chemistry to create hybrid synthetic protein mimetics and also offers materials science services to peptide therapeutic challenges, enabling medical professionals with the discovery and development of a new class of synthetic biologic drug modality to access challenging drug targets.

Sector
Healthcare
HQ
Chicago, IL, United States
Founded
2020
Employees
9
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.